24/7 Patient Assistance: 760-405-8205

Meera Ravindranathan, MD

Medical Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma

  • Bio & Insurance Information

    Dr. Meera Ravindranathan graduated from the Virginia Commonwealth University School of Medicine and completed her residency and fellowship program at the University of Texas Medical Branch Hospitals. She is specialized in Medical Oncology and board certified in Internal Medicine and Oncology. Dr. Ravindranathan has been in practice for more than 11 years and is affiliated with the Sharp Chula Vista Medical Center and the Sharp Coronado Hospital. During her career, she has also contributed to 3 research publications.



  • Education & Training

    dept_icon

    Virginia Commonwealth University School of Medicine

    Medical School

    dept_icon

    University of Texas Medical Branch Hospitals

    Residency

    dept_icon

    University of Texas Medical Branch Hospitals

    Fellowship

  • Board Certifications

    American Board of Internal Medicine

    American Board of Internal Medicine - Oncology

  • Hospital & Practice

    Sharp Chula Vista Medical Center

    Languages: English/Spanish

    (619) 502-5800

    751 Medical Center Ct

    Chula Vista, California 91911

    Read More

    Sharp Coronado Hospital

    Languages: English/Spanish

    619-522-3600

    250 Prospect Pl

    Coronado, California 92118

    Read More

    Sharp Grossmont Hospital

    Languages: English/Spanish

    (619 )740-6000

    5555 Grossmont Center Dr

    La Mesa, California 91942

    Read More

    Sharp Memorial Hospital

    Languages: English/Spanish

    858-939-3400

    7901 Frost St

    San Diego, California 92123

    Read More
  • Publications & Memberships

    Dr. Meera Ravindranathan has contributed to 3 publications.

    Response of intracranial metastases to erlotinib therapy.

    Fekrazad, M. H., Ravindranathan, M., Jones, D. V.; J Clin Oncol. 2007 Nov 1

    See more >>

    A phase I study of 5-azacytidine and erlotinib in advanced solid tumor malignancies.

    Bauman, J., Verschraegen, C., Belinsky, S., Muller, C., Rutledge, T., Fekrazad, M., Ravindranathan, M., Lee, S. J., Jones, D.; Cancer Chemother Pharmacol. 2012 Feb.

    See more >>

    A Phase I Protocol of Hydralazine and Valproic Acid in Advanced, Previously Treated Solid Cancers.

    Bauman, J.,Shaheen, M.,Verschraegen, C. F.,Belinsky, S. A.,Houman Fekrazad, M.,Lee, F. C.,Rabinowitz, I.,Ravindranathan, M.,Jones, D. V.; Transl Oncol. 2014 Apr 22.

    See more >>